RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer

被引:19
作者
Zhang, Shengwei [1 ]
Wang, Jing [2 ]
Hu, Weichao [1 ]
He, Lijiao [1 ]
Tang, Qingyun [1 ]
Li, Jie [1 ]
Jie, Mengmeng [1 ]
Li, Xinzhe [1 ]
Liu, Cheng [1 ]
Qin, Ouyang [3 ]
Yang, Shiming [1 ,4 ,5 ]
Hu, Changjiang [1 ,4 ,5 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China
[2] Southwest Univ, Med Res Inst, Chongqing, Peoples R China
[3] Third Mil Med Univ, Coll Pharm & Lab Med, Dept Pharmaceut Chem, Chongqing, Peoples R China
[4] Chongqing Municipal Clin Res Ctr Gastroenterol, Chongqing, Peoples R China
[5] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing 400037, Peoples R China
基金
中国国家自然科学基金;
关键词
TRANSCRIPTION FACTOR; DEGRADATION; PROTECTS; TARGET; CELLS;
D O I
10.1172/jci.insight.166698
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Forkhead box M1 (FOXM1) plays a critical role in development physiologically and tumorigenesis pathologically. However, insufficient efforts have been dedicated to exploring the regulation, in particular the degradation of FOXM1. Here, the ON-TARGETplus siRNA library targeting E3 ligases was used to screen potential candidates to repress FOXM1. Of note, mechanism study revealed that RNF112 directly ubiquitinates FOXM1 in gastric cancer, resulting in a decreased FOXM1 transcriptional network and suppressing the proliferation and invasion of gastric cancer. Interestingly, the well-established small-molecule compound RCM-1 significantly enhanced the interaction between RNF112 and FOXM1, which further promoted FOXM1 ubiquitination and subsequently exerted promising anticancer effects in vitro and in vivo. Altogether, we demonstrate that RNF112 suppresses gastric cancer progression by ubiquitinating FOXM1 and highlight the RNF112/FOXM1 axis serves as both prognosis biomarker and therapeutic target in gastric cancer.
引用
收藏
页数:18
相关论文
共 50 条
[41]   MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1 [J].
Wang, Quan ;
Yu, Jinhai .
BIOCHEMISTRY AND CELL BIOLOGY, 2018, 96 (01) :19-25
[42]   Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression [J].
Nandi, Ipshita ;
Smith, Harvey W. ;
Sanguin-Gendreau, Virginie ;
Ji, Linjia ;
Pacis, Alain ;
Papavasiliou, Vasilios ;
Zuo, Dongmei ;
Nam, Stella ;
Attalla, Sherif S. ;
Kim, Sung Hoon ;
Lusson, Sierra ;
Kuasne, Hellen ;
Fortier, Anne -Marie ;
Savage, Paul ;
Ramirez, Constanza Martinez ;
Park, Morag ;
Katzenellenbogen, John A. ;
Katzenellenbogen, Benita S. ;
Muller, William J. .
JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (07)
[43]   Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer [J].
Su, Bo ;
Su, Jian ;
Zeng, Ying ;
Liu, Fang ;
Xia, Hong ;
Ma, Yan-Hua ;
Zhou, Zhi-Gang ;
Zhang, Shuo ;
Yang, Bang-Min ;
Wu, You-Hua ;
Zeng, Xi ;
Ai, Xiao-Hong ;
Ling, Hui ;
Jiang, Hao ;
Su, Qi .
ONCOTARGET, 2016, 7 (09) :10498-10512
[44]   Reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis [J].
Wu, Jugang ;
Tian, Baoxing ;
Yang, Jianjun ;
Huo, Haizhong ;
Song, Zhicheng ;
Yu, Jiwei ;
Gu, Yan .
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) :774-785
[45]   FOXM1 overexpression and decreased E-cadherin expression are correlated with poor prognosis advanced gastric cancer [J].
Guo, Pengda ;
Liu, Rongrong ;
Bai, Guanghui ;
Ying, Lijie ;
He, Xiansong ;
Zheng, Renzhi ;
Jiang, Xiaofeng ;
Li, Fengyue ;
Jia, Ruofan ;
Lou, Xiao ;
Liu, Songbai .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05) :5689-5695
[46]   Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells [J].
Miao, Lifeng ;
Xiong, Xianze ;
Lin, Yixin ;
Cheng, Yao ;
Lu, Jiong ;
Zhang, Jie ;
Cheng, Nansheng .
CANCER GENETICS, 2014, 207 (03) :75-82
[47]   Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients [J].
Li, X. ;
Qi, W. ;
Yao, R. ;
Tang, D. ;
Liang, J. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (03) :307-314
[48]   Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression [J].
Wang, Kun ;
Dai, Xiaoyong ;
Yu, Albert ;
Feng, Chunyan ;
Liu, Kewei ;
Huang, Laiqiang .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
[49]   TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1 [J].
Zheng, Shuier ;
Zhou, Chenliang ;
Wang, Yonggang ;
Li, Hongtao ;
Sun, Yong ;
Shen, Zan .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
[50]   Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1 [J].
Wei, Ji-chao ;
Meng, Fan-di ;
Qu, Kai ;
Wang, Zhi-xin ;
Wu, Qi-fei ;
Zhang, Ling-qiang ;
Pang, Qing ;
Liu, Chang .
ACTA PHARMACOLOGICA SINICA, 2015, 36 (02) :241-251